Forbes
HealthDay News notes that patients with a variety of advanced cancers who
had been faring poorly on less finely tuned therapies did better when they
received treatments that were targeted to their tumors' specific
characteristics. Two studies, presented Sunday at the American Association for
Cancer Research annual meeting in Denver, focused on the brain tumors known as
glioblastomas. One from researchers at the University of Pennsylvania indicated
that an imaging technique known as magnetic resonance perfusion-weighted imaging
may be able to identify genetic mutations which could then help guide treatment
choices. With further validation, these findings may result in use of the
procedure in clinical trials and, further down the line, actual practice, said
Dr. Deepa Subramaniam, director of the brain tumor center at Lombardi
Comprehensive Cancer Center, Georgetown University, in Washington, D.C. Read More
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
